Dermatologists are increasingly prescribing minoxidil in low-dose pills to help men and women regrow hair. The practice ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares shot up 2.1% during trading on Wednesday after Bank of America raised their price target on the stock from $21.00 to $22.00. Bank of ...

While swiping left and right have become synonymous with dating culture among younger generations, a 2025 Hims study found ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

As the U.S. stock market navigates a mixed trading environment, with major indices struggling to extend their recent rebound rally, investors are closely watching for signs of economic stability amid ...

Hologic HOLX has been gaining from new strategic product launches across Diagnostics and Breast Health. However, ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Eli Lilly (LLY) launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk (NVO) for a ...

Thermo Fisher Scientific TMO has unveiled the Thermo Scientific Vulcan Automated Lab, a cutting-edge solution designed to drive a new era of process development and control in semiconductor ...

The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...